These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. The role of vasodilators in patients with progressive systemic sclerosis. Interstitial lung disease and pulmonary hypertension. Ohar J; Polatty C; Robichaud A; Fowler A; Vetrovec G; Glauser F Chest; 1985 Oct; 88(4 Suppl):263S-265S. PubMed ID: 4042734 [TBL] [Abstract][Full Text] [Related]
17. Factors relating to impaired stroke volume during the 6-minute walk test in patients with systemic sclerosis. Someya F; Mugii N; Oohata S Clin Exp Rheumatol; 2016; 34 Suppl 100(5):152-156. PubMed ID: 27463117 [TBL] [Abstract][Full Text] [Related]
18. The efficacy of treatment for systemic sclerosis interstitial lung disease: results from a meta-analysis. Broad K; Pope JE Med Sci Monit; 2010 Sep; 16(9):RA187-90. PubMed ID: 20802426 [TBL] [Abstract][Full Text] [Related]
20. Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis. Zhang XJ; Bonner A; Hudson M; ; Baron M; Pope J J Rheumatol; 2013 Jun; 40(6):850-8. PubMed ID: 23547215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]